Partly due to physiological adrenal uptake of 68Ga-DOTA-SSA PET/CT, more tumor specific 18F-FDOPA PET/CT may be preferred in PCCs that are small and/or related to known mutations in NF1, RET, VHL, or MAX (55, 81, 88). This evidence concerns the gene NF1 and neoplasm.